Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantp < 0.051.0× alphagold
Patients receiving etanercept monotherapy had less deterioration of PtGA and PtJP scores versus those assigned to methotrexate monotherapy, with a nominally significant treatment difference observed at almost all time points for PtGA and PtJP at weeks 12 and 36 ( p < 0.05; Fig. 1 ).
nominally significantP < 0.051.0× alphagold
We performed the association analyses with FG, FI, HOMA-B, HOMA-IR and BMI SDS for the 42 variants, assuming an additive genetic model implemented in linear regression and detected nominally significant associations ( P < 0.05) at eight FG, eight T2D and two FI loci with the phenotypes tested (Material and Methods, Supplementary Material, Table S1 ).
nominally significantP < 0.051.0× alphagold
The majority of the hypomethylated (20/28) sites showed lower M-values in the SWD group as compared with the controls; accordingly, the majority (9/10) of the hypermethylated showed higher M-values in SWD (one site, cg13823003 from GRIN2C , with a nominally significant difference at P < 0.05, analysis of variance (ANOVA) (Supplementary Table S6 ).
nominally significantp < 0·051.0× alphagold
After Bonferroni correction, the rs1800450 exonic polymorphism in MBL2 demonstrated statistically significant association with TBI outcome ( p = 5·24 × 10 −4 ), followed by three nominally significant ( p < 0·05, uncorrected) associations (rs1800629 in TNF ; rs5030737 and rs7096206 in MBL2 ) (Supplementary Table 5).
nominally significantp < 0.051.0× alphagold
While the 19 exome-wide significant genes were not significantly associated (all p > 4.38 × 10 −4 , Bonferroni adjustment for 19 unique genes × 6 phenotypes) with any other tissue-specific fat components, we observed that nominally significant associations ( p < 0.05) generally shared the expected direction of effect on the primary and supplemental phenotypes ( Figures 2 and S3 ).